On Oct. 7, 2021, BD (Becton, Dickinson) announced it had strengthened the U.S. government’s access to safety injection devices through increased manufacturing capacity and domestic supply.

The new syringe and needle manufacturing lines, which were completed on an accelerated timeline, represented the public-private partnership between BD and Department of Health and Human Services.